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Abstract
The daily consumption of natural antioxidants protects against oxidative damage caused by reactive oxygen species
(ROS), including DNA damage, and can reduce the risk of cancer, atherosclerosis and other degenerative diseases.
The pulp of pequi (Caryocar brasiliense Camb.) fruit, a tree native to the Brazilian savannah, contains several com-
pounds with antioxidant properties, including carotenoids, vitamin C, phenolic compounds such as flavonoids, sapo-
nins and tannins, and essential oils. In this work, we examined the ability of organic and aqueous extracts of pequi
fruit pulp to protect against the genotoxicity induced by two antineoplastic drugs, cyclophosphamide (CP) and
bleomycin (BLM). Micronucleus tests with mouse bone marrow cells and single-cell gel electrophoresis (comet as-
say) with peripheral blood leukocytes were used to examine the effects of CP and BLM, respectively. The antioxidant
activity of the extracts was assessed by measuring lipid peroxidation with the TBARS method in mouse plasma. The
fruit pulp extracts had no clastogenic or genotoxic effects in the cells studied, but both extracts protected against oxi-
dative DNA damage caused by BLM or CP, indicating an ability to inhibit chemical mutagenesis in vivo. However, the
protective effect against oxidative DNA damage depended on the dose of extract used. At the doses tested, the
aqueous extract enhanced lipid peroxidation in mice of both sexes, especially in males. In contrast, the organic ex-
tract enhanced lipid peroxidation only in male mice, with no significant effect in females. These results suggest that,
with adequate adjustment of the dose, an organic extract of pequi fruit pulp could be a useful dietary supplement with
natural antioxidant activity, at least in females.
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Introduction
The pequi tree (Caryocar brasiliense Camb.), which
belongs to the family Caryocaraceae, is very common in the
Brazilian savannah (“cerrado”). Pequi fruit has an internal
mesocarp (pequi pulp) that is used in folk medicine to treat
a number of respiratory diseases (Almeida and Silva, 1994;
Ramos et al., 2001). Each 100 g of pulp contains 20%-27%
lipids that constitute the pulp oil, 2.2-6.0% protein, 11.6%
fibers, 19.7% total carbohydrates and 225-267.9 kcal (Al-
meida, 1998; Boletim Informativo UFMG nº 1511, 2005).
According to Almeida (1998), the fatty acid composition of
pequi pulp oil consists of 51% mono-unsaturated acids,
mainly oleic acid, 49% saturated oils (principally palmitic
acid) and ~2% polyunsaturated linoleic acid.
Pequi oil is also used in folk medicine for treating
ophthalmic problems related to vitamin A deficiency, a use
supported by the high content of carotenoids with pro-
vitamin A activity (Almeida and Silva, 1994; Almeida,
1998; Ramos et. al, 2001; Santos et al., 2005; Oliveira et
al., 2006). In addition to β-carotene, pequi pulp contains
other carotenoids, such as lycopene (Oliveira et al., 2006),
ζ-carotene, cryptoflavin, β-cryptoxanthine, anteraxanthi-
ne, zeaxanthine, mutatoxanthine, violanxanthine, lutein
and neoxanthine (Ramos et al., 2001; Azevedo-Meleiro
and Rodriguez-Amaya, 2004; Oliveira et al., 2006). Pequi
pulp is also rich in vitamin C (Barbosa and Amante, 2005).
W. Paula-Júnior (MSc Dissertation, Federal University of
Paraná, Brazil, 2004) identified phenolic compounds, such
as flavonoids, saponins and essential oils in hydroethanolic
extracts of the internal mesocarp of pequi pulp, and Al-
meida (1998) reported a tanin content of 0.17 mg/100 g of
pulp. All of these components of pequi pulp have antioxi-
dant properties (Sies, 1993; Tseng et al., 2004).
Natural antioxidants in the human diet can attenuate
the effects of mutagens and genotoxic carcinogens. Some
antioxidants, such as vitamins A, C and E, minimize the
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side effects of antineoplastic drugs and can improve cancer
chemotherapy. An increase in the dietary content of antiox-
idants through the increased ingestion of fruits and vegeta-
bles rich in these compounds can decrease the oxidation of
DNA by free radicals, thereby preventing cancer and other
degenerative diseases. Oxidative damage to biomolecules
caused by stress is one of the major risk factors for athero-
sclerosis, mainly through the oxidation of low density lipo-
protein (LDL) in the blood. Thus, cancer, atherosclerosis
and many other degenerative diseases share a common
mechanism (Kong and Lillehei, 1998; Santos and Cruz,
2001; Dusinská et al., 2003).
Some dietary antioxidants can act as adjuvants in can-
cer therapy because of their ability to induce apoptosis in
vitro. Antioxidants also show promise in cancer therapy be-
cause of their palliative action in reducing painful side ef-
fects associated with chemotherapy (Borek, 2004). Khouri
et al. (2007) showed that an aqueous extract of pequi pulp
can prevent mouse bone marrow cells against chromo-
somal aberrations induced by bleomycin. Experiments with
cultured CHO-K1 cells also showed that this aqueous ex-
tract protected cells against the clastogenic effects of cyclo-
phosphamide.
In this study, the anticlastogenic potential of an or-
ganic extract of pequi was evaluated in mice bone marrow
cells in vivo by using the micronucleus assay. The antigeno-
toxic effects of aqueous (AEP) and organic (OEP) extracts
of pequi pulp were also evaluated by single-cell gel electro-
phoresis (SCGE - comet assay) in mouse peripheral blood
leukocytes. The antioxidant activity of AEP and OEP on
lipid peroxidation in mouse blood was assessed by the
thiobarbituric acid-reactive substances (TBARS) assay.
Materials and Methods
Chemicals
Bleomycin (BLM) (CAS 011056-06-7) was obtained
as Bleoxane sulphate from Bristol-Myers (São Paulo, Bra-
zil) and cyclophosphamide (CP) (CAS 6055-19-2), sold a
Genuxal, was from ASTA Medica Laboratory (São Paulo,
Brazil).
Plant material
Pequi fruit was obtained in natura from vendors in
Brasília, DF (Brazil) and the surrounding region. The inter-
nal mesocarp was peeled or grated to obtain the pulp, which
was then packed in a covered pot and frozen to -86 °C.
Extraction procedure
Pequi pulp was extracted by the soxhlet procedure un-
der an argonium atmosphere using chloroform (organic ex-
tract of pequi pulp - OEP) or distilled water (aqueous
extract of pequi pulp - AEP) as the solvent. After extrac-
tion, the extracts were submitted to evaporation under re-
duced pressure to remove the solvents, dried at high vac-
uum and immediately frozen at -86 °C.
Animals
Swiss white mice of both sexes (60 days old, 30 ± 2 g)
obtained from the Central Animal Facility of the University
of Brasília were housed in plastic cages (6 or 8/cage) at
room temperature (20 ± 2 °C) on a 12 h light/dark cycle
with lights on at 6 a.m. and free access to food and water.
The experimental protocols described here were approved
by the institutional Ethics Committee for Animal Research
(Institute of Biological Science, University of Brasília).
Anticlastogenic and antigenotoxic assays
Micronucleus (MN) test
For the MN test, only the OEP was used since the
AEP has already been studied by Khouri et al. (2007). Mice
of both sexes were randomly allocated to groups M1 to
M12 (n = 8 mice/group; Table 1). OEP (0.5 mL kg-1 or 1 mL
kg-1 of body weight, respectively, corresponding to 15 μL
and 30 μL of extract per mouse) was administered orally
(per os, p.o.) by gavage daily for 10 days either alone or in
combination with a single intraperitoneal (i.p.) injection of
bleomycin diluted in 0.9% NaCl or aqueous cyclophos-
phamide (see Table 1 for concentrations). Control mice re-
ceived filtered water in place of extract and no clastogen
was administered. When required, the mice were killed by
cervical dislocation and slides of bone marrow cells were
prepared by a standard method (Schmid, 1975). Two thou-
sand erythrocytes were counted per mouse (1000 normo-
chromatic erythrocytes, NCE, and 1000 polychromatic
erythrocytes, PCE) and the frequency of micronuclei (MN)
in PCE and NCE, and the percentage of polychromatic
erythrocytes (%PCE) were calculated.
Single-cell gel electrophoresis (SCGE) assay
(comet assay)
The SCGE assay was done essentially as for the MN
test, using mice of both sexes randomly allocated to groups
C1 to C9 (n = 8 mice/group; Table 2). The comet assay was
done after the MN test, using OEP (0.5 mL hg-1) and AEP
(1 mL kg-1) administered p.o. daily for 10 days, either alone
or in combination with a single injection of bleomycin
(25 mg kg-1, i.p.) or two injections of cyclophosphamide (at
30 mg kg-1, i.p. 48 h and 24 h before the mice were killed)
(Table 2).
The comet assay (alkali method) proposed by Singh
et al. (1988) and improved by Tice (1995) was used. Micro-
scope slides were dipped briefly into 1.5% hot (60 °C) nor-
mal melting agarose prepared in phosphate-buffered saline
(PBS). The slides were dried overnight at room temperature
and then stored at 4 °C until used. Subsequently, freshly
collected, heparinized peripheral blood (20 μL) was sus-
pended in 120 μL of 0.5% low melting point agarose in
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PBS (Gibco BRL) at 37 °C and pipetted onto a microscope
slide pre-coated with a layer of normal melting point
agarose. This mixture was allowed to set at 4 °C for 10 min
and the slides then immersed in a freshly prepared cold
(4 °C) lysis solution (2.5 M NaCl, 100 mM Na2EDTA, 10
mM Tris and 1% lauroyl sarcosine, and the pH adjusted to
pH 10.0-10.5 with NaOH; 1% Triton X-100 and 10%
dimethyl sulfoxide were added immediately before use) at
4 °C for 1 h. After lysis, the slides were placed in an electro-
phoretic tank containing 300 mM NaOH and 1 mM EDTA,
pH > 13.0 for 30 min, and electrophoresis was then done at
25 V, 350 mA for 40 min. Soon after neutralization (3 x
5 min in 0.4 M Tris, pH 7.5 at 4 °C), the slides were stained
with ethidium-bromide (20 μg/mL), fixed in 100% ethanol
for 5 min and analyzed with a Zeiss Axioskop 2 fluores-
cence microscope (filter 510-560 nm, barrier filter 590 nm)
with a final magnification of 400x. All of the slides were
prepared and analyzed in duplicate.
SCGE analysis: One hundred comets on each slide
were scored visually and assigned to classes 0-4, as pro-
posed by Collins (1995). Nucleoids with bright heads and
no apparent tails were assigned to category 0, whereas com-
ets with very small heads and long, diffuse tails were as-
signed to category 4. Comets with intermediate features
between classes 0 and 4 were assigned to classes 1, 2 and 3.
The number of comets in each category was counted and
the average DNA damage (DD, expressed in arbitrary
units, a.u.) was calculated according to Jalonszynski et al.
(1997), as follows:
DD




1 2 3 4
2 3 4
100
where n1- n4 = the number of comets in categories 1-4, and
Σ = the sum of all comets, including category 0.
In vivo antioxidant assay: thiobarbituric acid-reactive
substances (TBARS) test
For the TBARS test, six groups (T1-T6) of eight mice
each (4 males, 4 females) were used, as follows:
T1: Female control group (filtered water only, by ga-
vage, daily, for 10 days)
T2: Male control group (filtered water only, by ga-
vage, daily, for 10 days)
T3: Females treated with OEP (0.5 mL kg-1, by ga-
vage, daily for 10 days)
T4: Males treated with OEP (0.5 mL kg-1, by gavage,
daily for 10 days)
T5: Females treated with AEP (1.0 mL kg-1, by ga-
vage, daily for 10 days)
T6: Males treated with AEP (1.0 mL kg-1, by gavage,
daily for 10 days)
The TBARS assay was done according to Wasowicz
et al. (1993), with slight modification. The TBA solution









































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































was prepared by dissolving TBA (Merck; final concentra-
tion 29 mmol/L) in acetic acid (8.75 mol/L; Merck). The
stock standard solution of MDA was prepared by dissolv-
ing 480 μL of 1,1,3,3-tetraethoxypropane (Sigma) in
100 mL of ethanol (Merck). Immediately before use, the
solution was diluted in Milli-Q water to yield a working so-
lution of 10 μmol/L. The other reagents for the assay were
purchased from Sigma (n-butanol) or Merck (EDTA, gluta-
thione - GSH, and hydrochloric acid). Working aqueous so-
lutions of EDTA (67.3 mmol/L) and GSH (32.5 mmol/L)
were prepared freshly immediately before use (to avoid
GSH oxidation).
Blood was collected by cardiac puncture using na in-
sulin syringe containing EDTA as anticoagulant. After cen-
trifugation (1500 x g, 10 min, 4 °C), the plasma was
carefully removed and EDTA and GSH were added to final
concentrations of 1.34 mmol/L and 0.65 mmol/L, respec-
tively. The samples were then quickly frozen in liquid ni-
trogen and stored at -80 °C until used.
For the TBARS test, 50 μL of plasma or an equal vol-
ume of MDA working standard was added to 10 mL glass
tubes containing 1 mL of Milli-Q water, followed by 1 mL
of solution containing TBA (29 mmol/L) in acetic acid (pH
of the reaction mixture, 2.4-2.6), mixing, and heating in a
water bath for 1 h at 95° -100 °C. The samples were then
cooled and 25 μL of 5 mol/L HC1 was added (final pH
1.6-1.7), followed by extraction with 3.0 mL of n-butanol
and vortex mixing for 30 s. The butanol phase was sepa-
rated by centrifugation (1500 x g, 10 min) and its fluores-
cence was measured with a Jasco FP-777 spectrofluoro-
meter (excitation: 525 nm, emission: 547 nm). A standard
curve was prepared with MBA (0-0.15 μmol/L).
Statistical analysis
The results were expressed as the mean ± SD. Statisti-
cal comparisons were done by using the Mann-Whitney
U-test, with p < 0.05 indicating significance.
Results
Anticlastogenic and antigenotoxic assays
Micronucleus (MN) test
Neither of the doses of OEP (1 mL kg-1 - group M3 or
0.5 mL kg-1 - group M8) had any clastogenic effect on
mouse bone marrow cells when compared with the control
group (M1) (Table 1). However, the cellular proliferation
index in mouse bone marrow cells, expressed as the per-
centage of PCE, increased in groups M3 and M8
(p = 0.0117 and p = 0.0460, respectively). There was no sig-
nificant difference in the frequencies of MN-PCE
(p = 0.5780), MN-NCE (p = 0.7004) and the cellular prolif-
eration index (p = 0.9163) between groups M3 and M8.
Cyclophosphamide (30 mg kg-1, group M2) increased the
frequency of MN-PCE, indicating this drugs clastogenic ef-
fect. Concomitant treatment with OEP (0.5 mL kg-1, group
M9) did not significantly affect the percentage of PCE
compared to M2. In contrast, concomitant treatment with
OEP (1 mL kg-1, group M4) increased the frequency of
MN-PCE to a greater extent than seen with CP or OEP
alone (p = 0.0309).
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Table 2 - Comet assay of peripheral leukocytes from Swiss white mice treated orally with an organic (OEP, 0.5 mL kg-1) or aqueous (AEP, 1 mL kg-1) ex-
tract of pequi (Caryocar brasiliense) fruit pulp, alone or with bleomycin (BLM, single injection, i.p.) or cyclophosphamide (CP, two injections, i.p.).
Group Treatment Comet classes (mean±SD) Mean±SD of DD
0 1 2 3 4
C1 Control group (filtered water) 11.62 ± 5.34 61.25 ± 18.7 22 ± 10.4 4.75 ± 5.6 0.38 ± 0.52 121 ± 20.89
C2 CP (30 mg kg-1, i.p., 48 and 24 h before sac-
rifice)
3.63 ± 2.88 6.63 ± 4.84 10.38 ± 6.80 31.88 ± 12.45 47.63 ± 13.75 313.5 ± 26.91a
C3 OEP (0.5 mL kg-1, p.o., daily for 10 days) 12 ± 7.98 46 ± 20.78 26.29 ± 8.03 5.57 ± 8.55 9.57 ± 18.61 171.13 ± 68.18
C4 OEP (0.5 mL kg-1, p.o., daily for 10 days) +
CP (30 mg kg-1, i.p., 48 and 24 h before sac-
rifice)
21 ± 10.40 41.5 ± 24.57 14.88 ± 9.73 14.5 ± 15.67 7.5 ± 9.75 144.75 ± 57.22b
C5 BLM (25 mg kg-1, i.p., 24 h before sacrifice) 4.29 ± 2.81 36.5 ± 12.99 47 ± 13.53 13.75 ± 10.36 2.13 ± 3.44 180.25 ± 39.96c
C6 OEP (0.5 mL kg-1, p.o., daily for 10 days) +
BLM (25 mg kg-1, i.p., 24 h before sacrifice)
8.38 ± 6.74 39 ± 13.42 41.5 ± 15.48 9.25 ± 6.78 2.0 ± 2.98 157.75 ± 27.03d
C7 AEP (1 mL kg-1, p.o., daily for 10 days) 9.75 ± 7.06 39.88 ± 13.91 29.88 ± 14.09 12.38 ± 14.94 8.13 ± 7.07 169.25 ± 33.13
C8 AEP (1 mL kg-1, p.o., daily for 10 days)
+CP (30 mg kg-1, i.p., 48 and 24 h before
sacrifice)
2.0 ± 1.85 68 ± 10.81 21.88 ± 9.49 5.13 ± 3.76 3.0 ± 3.38 139.13 ± 16.57e
C9 AEP (1 mL kg-1, p.o., daily for 10 days) +
BLM (25 mg kg-1, i.p., 24 h before sacrifice)
6.13 ± 6.10 62.5 ± 16.48 27.63 ± 13.64 1.63 ± 2.26 2.13 ± 3.09 131.13 ± 14.29f, g
ap = 0.0008 compared to C1. bp = 0.0008 compared to C2. cp = 0.0016 compared to C1. dp = 0.0134 compared to C1. ep = 0.0008 compared to C2.
fp = 0.0273 compared to C6. gp = 0.0023 compared to C5.
Bleomycin (50 mg kg-1; group M5) was clearly cyto-
toxic and caused cellular lysis (no erythroblasts were seen).
At a dose of 25 mg kg-1, bleomycin did not significantly al-
ter the frequency of MN-PCE (group M7 vs. M1), but
caused significant induction at 10 mg kg-1 (group M11), in-
dicating a clastogenic effect on these cells. Comparison of
groups M5 and M6 showed that OEP (1 mL kg-1) clearly
protected bone marrow cells against bleomycin (50 mg
kg-1)-induced lysis (p = 0.0003 for MN-PCE, p = 0.0011 for
MN-NCE and p = 0.0003 for %PCE). On the other hand,
the combination of OEP (0.5 mL kg-1) + bleomycin (25 mg
kg-1) (group M10) did not significantly affect MN-PCE, but
reduced MN-NCE when compared with group M7
(p = 0.0332). Although the combination OEP (0.5 mL kg-1)
+ bleomycin (10 mg kg-1) (group M12) did not significantly
decrease MN-PCE when compared with group M11, it sig-
nificantly increased (p = 0.0357) the %PCE relative to the
latter group.
Single-cell gel electrophoresis assay (SCGE - comet
assay)
Table 2 shows the results of the comet assay in pe-
ripheral blood leukocytes of mice treated with OEP (0.5 mL
kg-1; group C3) and AEP (1 mL kg-1; group C7). Neither
OEP (C3) nor AEP (C7) significantly affected the DNA
damage (DD) compared to group C1 (negative control), in-
dicating that the extracts had no genotoxic effect in these
cells. Likewise, there was no significant difference between
C3 and C7. CP (30 mg kg-1; C2) and BLM (25 mg kg-1; C5)
were significantly genotoxic when compared with C1
(p = 0.0008 and p = 0.0016, respectively). However, there
was no significant difference between C1 and C4 (OEP
0.5 mL kg-1 + CP 30 mg kg-1) or C8 (AEP 1 mL kg-1 + CP
30 mg kg-1), indicating that at the doses tested OEP and
AEP were efficient in protecting cells against the genoto-
xicity of CP (30 mg kg-1). Comparison of C2 with C4 and
C8 corroborated this protective effect (p = 0.0008 in both
cases), although there were no significant differences be-
tween C4 and C8. When group C1 was compared with C6
(OEP 0.5 mL kg-1 + BLM 25 mg kg-1) or C9 (AEP 1 mL
kg-1 + BLM 25 mg kg-1), only AEP showed significant pro-
tection (p = 0.0134). Similar protection was seen in the
comparison of C6 with C9 (p = 0.0273) and C5 with C9
(p = 0.0023), indicating that AEP provided greater protec-
tion than OEP against bleomycin (25 mg kg-1)-induced
DNA damage; there was no difference between C5 (BLM
25 mg kg-1) and C6.
Antioxidant activity (TBARS assay)
There was no significant difference in the TBARS
levels of female (group T1) and male (group T2) mice (Ta-
ble 3). There were also no significant differences between
T1 and T3, T3 and T5 or T4 and T6. However, mice treated
with AEP showed significant lipid peroxidation (p = 0.0248
for T1 vs. T5, and p = 0.0001 for T2 vs. T6), indicating that
AEP (1 mL kg-1) enhanced oxidative stress in both sexes,
especially in males. A similar result was observed between
control males and males treated with OEP (0.5 mL kg-1) (T2
vs. T4, p = 0.00002). Thus, at the doses used, neither of the
extracts protected males against lipid peroxidation.
Discussion
Micronuclei in interphase cells result from chromo-
somal breaks or chromosomal lagging (Schmid, 1975; Na-
tarajan and Obe, 1982; FDA, 2000), and DNA damage to
eukaryotic organisms or individual cells is frequently as-
sessed with the comet assay (Henderson et al., 1998; Garcia
et al., 2004). In the present study, the MN test and comet as-
say showed that OEP (0.5 mL kg-1 or 1 mL kg-1) had no
clastogenic or genotoxic effect on mouse bone marrow
cells or peripheral blood lymphocytes, a finding that cor-
roborated the MN test results reported by Khouri et al.
(2007).
Bleomycin sulphate (BLM), a radiomimetic glyco-
peptide routinely used in cancer chemotherapy, produces
MN in human, rat and mouse cells, mainly through oxida-
tive damage to DNA (Erexson et al., 1995). Bleomycin-
mediated DNA degradation requires the presence of a re-
dox-active metal ion such as Fe2+ or Cu2+, as well as molec-
ular oxygen, to produce reactive oxygen species (ROS) that
are toxic and mutagenic in a variety of biological models in
vitro and in vivo (Hoffmann et al., 1993; Anderson et al.,
1995; Erexson et al., 1995; Hecht, 2000).
960 DNA protective effects of pequi fruit pulp extracts
Table 3 - Lipid peroxidation (TBARS levels) in plasma of Swiss white mice treated orally an organic (OEP, 0.5 mL kg-1) or aqueous (AEP, 1 mL kg-1) ex-
tract of pequi (Caryocar brasiliense) fruit pulp.
Group Treatment Fluorescence (mean±SD) MDA (μmol/L) (mean±SD)
T1 Female control group (filtered water) 311.16 ± 41.26 0.023 ± 0.003
T2 Male control group (filtered water) 307.9 ± 18.17 0.023 ± 0.001
T3 Females treated with OEP (0.5 mL kg-1, p.o., daily for 10 days) 337.31 ± 39.59 0.025 ± 0.003
T4 Males treated with OEP (0.5 mL kg-1, p.o., daily for 10 days) 421.36 ± 46.29a 0.031 ± 0.003
T5 Females treated with AEP (1 mL kg-1, p.o., daily for 10 days) 345.0 ± 28.42b 0.026 ± 0.002
T6 Males treated with AEP (1 mL kg-1, p.o., daily for 10 days) 392.2 ± 39.95c 0.029 ± 0.003
ap = 0.00002 compared to T2. bp = 0.0248 compared to T1. cp = 0.0001 compared to T2.
As shown here, the prior administration of OEP
(1 mL kg-1) clearly protected mouse bone marrow cells
against lysis induced by BLM (50 mg kg-1); a lower dose of
OEP (0.5 mL kg-1) also protected against the natural clasto-
genic effects, although the decrease in MN-NCE was not
significant. Hence, both of the OEP doses used offered
some protection against the clastogenicity of BLM. This
finding was corroborated by the comet assay. AEP (1 mL kg-1)
offered greater protection against BLM (25 mg kg-1)-in-
duced DNA damage than OEP (0.5 mL kg-1); the reduction
in DNA damage by the latter was not significant.
Since the cytotoxicity of BLM involves the produc-
tion of ROS (Hoffmann et al., 1993; Anderson et al., 1995;
Erexson et al., 1995; Hecht, 2000), our results suggest that
the protection against BLM-induced oxidative damage to
DNA was mediated by antioxidant components in the C.
brasiliense extracts. Indeed, previous studies have indi-
cated that compounds with antioxidant activities may mod-
ulate BLM-induced genotoxicity (Povirk and Austin, 1991;
Povirk, 1996; Khouri et al., 2007). The results of the comet
assay corroborated those of the MN test and showed that
the ability of the two extracts to protect against BLM was
limited by the dose of extract used. The greater protection
seen with AEP probably reflected its higher content of anti-
oxidants compared to that of OEP at the doses used.
Chemotherapy with CP can cause secondary tumors
in humans by activating hepatic mixed function oxidases.
Phosphoramide mustard, the major antineoplastic metabo-
lite of CP, is an alkylating agent that induces a variety of
changes in DNA (IARC, 1981; Krishna et al., 1987)
through its ability to form labile covalent DNA adducts and
cross-linkages (Anderson et al., 1995).
Compounds with antioxidant properties, such as vita-
min C (present in AEP) and β-carotene (present in OEP)
can have antioxidant and oxidant effects that are dose-
dependent (Antunes and Takahashi, 1999; Paolini et al.,
2003). This two-sided or Janus effect reflects the dual na-
ture of certain chemical substances such as antioxidants
and drugs used to treat cancer. As shown here, OEP had a
Janus effect: at 0.5 mL kg-1 OEP effectively protected cells
against the genotoxicity of CP (comet assay) without sig-
nificantly protecting against chromosomal aberrations
(MN test) whereas at 1 mL kg-1 OEP increased the fre-
quency of MN in the presence of CP (30 mg kg-1). Similar
results were reported by Khouri et al. (2007) who studied
the combination of AEP (1 mL kg-1) plus CP (33 mg kg-1 or
66 mg kg-1).
With the treatment schedule used here, it was not pos-
sible to determine whether the protection offered by the ex-
tracts was related to a reduction in the efficacy of BLM or
CP (by affecting the pharmacokinetics of these com-
pounds), or to a direct effect on the cells themselves. How-
ever, previous studies have shown that natural antioxidants
can prevent the oxidation of biomolecules, including DNA,
without decreasing the effectiveness of chemotherapeutic
compounds. According to Liu et al. (2003) and Berger
(2005), an antioxidant dietary supplement can reduce the
level of oxidative damage to DNA and protect normal cells
against the adverse side-effects of some chemotherapeutic
agents. Nutritional therapy with antioxidants concomitant
with chemotherapy reduces the frequency and severity of
adverse effects associated with many drugs in cancer pa-
tients, thereby allowing the treatment to be continued (the
toxicity of anti-cancer drugs is a frequent limitation to their
extended use) (Borek, 2004). As shown here, OEP and AEP
protected against oxidative DNA damage caused by BLM
or CP, which agrees with the ability of antioxidants to in-
hibit chemical mutagenesis in vivo and with studies show-
ing that plant extracts contain antioxidants that can protect
DNA against damage by ROS (Cano et al., 2003; Lee et al.,
2003; Owen et al., 2003; Khouri et al., 2007). However, our
results indicate that this protection is related to the dose of
extract used.
Organisms are constantly exposed to the action of
ROS and the presence of antioxidants in the diet can protect
against oxidative processes (Ferreira and Matsubara, 1997;
Degáspari and Waszczynskyj, 2004). In contrast, the use of
nutritional supplements with antioxidant properties is con-
troversial. Antunes and Takahashi (1999) showed that vita-
min C had antimutagenic activity only at certain concentra-
tions; at high concentrations this compound did not protect
against mutations but was cytotoxic to lymphocytes. Pao-
lini et al. (2003) reported that β-carotene prevented oxida-
tive lesions in DNA but stimulated cytochrome P450 enzy-
mes, leading to the bioactivation of pro-carcinogenic
agents such as those found in cigarette smoke. In agreement
with these studies, the OEP of pequi fruit may contain high
concentrations of many antioxidant compounds capable of
exerting a pro-oxidative effect and increasing DNA lesions
when combined with CP or BLM.
The TBARS assay is a simple, reliable and reproduc-
ible fluorometric method for assessing lipid peroxidation in
serum, and is based on the reaction between malondial-
dehyde (MDA), a byproduct of lipid peroxidation, and
thiobarbituric acid. Oxidative attack of cellular compo-
nents by ROS is a common phenomenon in the pathoge-
nesis of several human diseases, including cardiovascular
diseases (e.g., atherosclerosis), diabetes, various liver dis-
orders, and inflammatory rheumatic diseases. For this rea-
son, there is considerable interest in the quantification of
MDA in body fluids or cells (Wasowicz et al., 1993;
Jentzsch et al., 1996). The TBARS results obtained here in-
dicate that high doses of plant extracts rich in antioxidant
compounds can produce unexpected effects. Since the
1980s, there has been a considerable increase in the search
for natural antioxidants that can be included in the diet as a
substitute for synthetic antioxidants (Degáspari and Waszc-
zynskyj, 2004). The TBARS results obtained here in fe-
male mice suggest that the antioxidant properties of OEP
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make this product a potentially useful dietary supplement,
in addition to its other nutritional properties.
The anticlastogenic and antigenotoxic activities of
OEP seen in this study were attributable to its content of an-
tioxidants. However, the comet assay and MN test results
obtained here and by Khouri et al. (2007) indicate that, at
the doses used, AEP was more effective than OEP in pro-
tecting DNA against damage by clastogenic agents. How-
ever, the ability of OEP and AEP to protect against BLM-
or CP-induced oxidative damage to DNA depended on the
dose of extract used.
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